ICYMI, the Everest Group named the OpenClinica EDC the leading Major Contender in the 2024 Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment.
In the words of Nisarg Shah, the Everest Group’s Practice Director,
The EDC market has evolved significantly over the past few years, driven by clinical trials’ increasing complexity, multiple real-world data sources, and the demand for more efficient data management solutions. Providers are now focusing on developing comprehensive data management platforms that integrate data capture with advanced analytics and AI capabilities.
Additionally, there is a clear trend toward improving user experience through low-code functionalities that enable users to customize their workflows without extensive technical knowledge. This shift is a response to the growing need for real-time data insights and enhanced data accuracy.”
At OpenClinica, we couldn’t agree more.
To say all of us at OpenClinica are gratified that our continuous investment in our EDC system for clinical trials has been recognized by the Everest Group in its inaugural Electronic Data Capture (EDC) PEAK Matrix® Assessment is quite the understatement.
OpenClinica’s EDC named the leading Major Contender in the 2024 Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment.
Similar to Garter’s Magic Quadrant, the PEAK Matrix® is:
A proprietary framework for assessing the relative market success and overall capability of tech and tech service providers based on performance, experiences, ability, and knowledge….The PEAK Matrix® assessment process also includes provider customer reference interviews – a critical step that some other research firms exclude.
The PEAK Matrix® evaluates 15-25 best-in-class solutions based on the impact created in the market and the ability to deliver products successfully. In other words, the PEAK Matrix® is an objective, data-driven assessment that sponsors can use to help narrow the choice of a platform for electronic data capture in clinical trials.
For the Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment for 2024, market impact has three sub-dimensions:
- Market Adoption: Number of clients, revenue base and YoY growth
- Portfolio Mix: Diversity of client base across industries, geographies, environments and enterprise size class
- Value Delivered: Value delivered to the client based on customer feedback and other measures
Vision and capability has five sub-dimensions:
- Vision and Strategy: Vision for the client and itself; future roadmap and strategy
- Technology Capability: Technical sophistication and breadth/depth across the technology suite
- Flexibility and Ease of Development: Configurability/customize-ability, hosting and tenancy, integration, governance, and security and compliance
- Engagement and Commercial Model: Progressiveness, effectiveness, and flexibility of engagement and commercial models
- Support: Training, consulting, maintenance, and other support services
OpenClinica Ranks in EDC PEAK Matrix® Assessment
In particular, the OpenClinica EDC differentiates itself from other top EDCs with portfolio mix and its vision and capability, earning high marks in technology capability, flexibility and ease of deployment, engagement and commercial model, and support.
As OpenClinica customers know well, we have continuously invested in our EDC and our complementary product portfolio. Earlier this year, we debuted three major new features to our product suite and hundreds of enhancements to better meet the needs of our clinical trial customers.
The three new features are state-of-the-art automated study calendaring, casebook enhancements, and single sign-on to seamlessly integrate user roles and permissions between OpenClinica solutions. OpenClinica’s study calendar infrastructure is a powerful rules engine and a robust, tested system that manages complex branching conditions and exceptions and, in turn, enables sponsors, sites and patients to adhere to even the most complicated clinical trial schedules.
For a deep dive into why 500 customers from small startups to large platform trials chose OpenClinica, download the PEAK Matrix® Assessment – here.